 SAN FRANCISCO and SEATTLE, Aug. 10, 2021 PRNewswire -- Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. Nasdaq: ADPT, a biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced an ongoing research collaboration to broaden patient participation in Adaptives clinical studies. The initial two studies of the partnership involve Adaptives T-DetectTM diagnostic test. 